BRIAN C. CARR - Corporate Board Profile

SBA COMMUNICATIONS CORP

Filing Date	Source Excerpt
2013-03-28	Brian C. Carr, 51, has served as a director of SBA since May 2004. Since May 2012, Mr. Carr has been Chairman and Chief Executive Officer of Regional Diagnostic Laboratories, Inc. ... The Board has three standing Committees: the Audit Committee, the Compensation Committee and the NCG Committee. ... Brian C. Carr Member Audit Committee, Member Compensation Committee. ... During 2012, each of Messrs. Beebe, Carr, Cocroft, Krouse and Langer received the annual cash compensation for his service as a director. ... Mr. Carr received $65,000 cash fees, $72,957 stock awards, $36,390 option awards, total $174,347.
2014-03-27	Brian C. Carr, 52, has served as a director of SBA since May 2004. He is a member of the Audit Committee and the Compensation Committee. Mr. Carr received $68,226 in cash compensation for his service as a director, plus stock awards and option awards totaling $125,325, for a total of $193,551 in 2013.
2015-04-10	Brian C. Carr Independent Director Age: 53 Director since: 2004 Committees: Audit, Compensation. Mr. Carr received annual cash compensation and equity grants totaling $206,015 in 2014.
2016-04-01	Brian C. Carr Director since: 2004 Independent Age: 54 Committees: Audit Compensation In addition to being a private investor and business consultant, Mr. Carr serves as non-executive Chairman of the board of Regional Diagnostic Laboratories, Inc., a company founded by a large private equity firm and Mr. Carr in 2012 to invest in various types of domestic and international medical laboratories. Mr. Carrs experience includes international consulting in Brazil and China for one of the largest private equity firms with investments worldwide. Mr. Carr was a co-founder and from May 2008 to September 2009 the Chief Executive Officer of OralDNA Labs, a privately held salivary diagnostic company focused on the dental profession which was acquired by Quest Diagnostics. Mr. Carr previously served as Chairman and Chief Executive Officer of American Esoteric Laboratories, a company engaged in advanced clinical laboratory testing, before it was acquired by Sonic Healthcare Limited. Prior to that, Mr. Carr was the President and a member of the board of directors of AmeriPath, Inc., a publicly held anatomic pathology company. Mr. Carr is a CPA (inactive) and CMA (Certified Management Accountant).
2017-04-07	Brian C. Carr Director since: 2004 Independent Age: 55 Committees: Audit Compensation In addition to being a private investor and strategic advisor to numerous companies, since January 2014, Mr. Carr has served as non-executive Chairman, and from March 2012 to December 2013 as Chairman and Chief Executive Officer, of Regional Diagnostic Laboratories, Inc., a company founded by a large private equity firm to invest in various types of domestic and international medical laboratories. In October 2016, Mr. Carr joined the board of privately held Acuamark Diagnostics, Inc. (formerly iCareDx, Inc.), a biotechnology company formed with a leading scientist from Cornell which is developing various blood-based tests for the early detection of certain cancers. Mr. Carr was co-founder and previously served as Chief Executive Officer and a director of OralDNA Labs, a privately held diagnostic company to the dental profession which was acquired by Quest Diagnostics, one of the nation 2 largest laboratory providers. Mr. Carr was also a co-founder and previously served as Chairman and Chief Executive Officer of American Esoteric Laboratories, a company engaged in advanced clinical laboratory testing until it was acquired by publicly-held Sonic Healthcare Limited. Prior to that, Mr. Carr was President and a director of AmeriPath, Inc., a publicly-traded anatomic pathology company. Mr. Carr has previous experience in Big Four public accounting firms as well as international consulting in Brazil and China. He is a CPA (inactive) and CMA (Certified Management Accountant 6 inactive).
2018-04-04	Brian C. Carr Director since: 2004 Independent Age: 56 Committees: Audit Compensation Mr. Carr is an experienced investor, board member and strategic advisor to various companies. Since October 2017, Mr. Carr has served as an independent director for private equity-backed SingularBio, Inc., a San Francisco based diagnostic technology company. From January 2014 until June 2017, Mr. Carr served as non-executive Chairman, and from March 2012 to December 2013 as Chairman and Chief Executive Officer, of Regional Diagnostic Laboratories, Inc., a company founded by a large private equity firm to invest in various types of domestic and international medical laboratories. From October 2016 until May 2017, Mr. Carr was a board member of privately held Acuamark Diagnostics. Previously, Mr. Carr was a co-founder, Chief Executive Officer and director for OralDNA Labs, a privately held diagnostic company which was acquired by Quest Diagnostics. Mr. Carr was also a co-founder and the Chairman and Chief Executive Officer of American Esoteric Laboratories until it was acquired by publicly-held Sonic Healthcare Limited. Prior to that, Mr. Carr was President and a director of AmeriPath, Inc., a publicly-traded anatomic pathology company. Mr. Carr has previous experience in Big Four public accounting firms as well as international consulting in Brazil and China. He is a CPA (inactive) and CMA (Certified Management Accountant) (inactive).
2019-04-05	Brian C. Carr Director since: 2004 Independent Age: 57 Committees: Audit Compensation Mr. Carr is an experienced investor, board member and strategic advisor to various companies. Since October 2017, Mr. Carr has served as an independent director for private equity-backed SingularBio, Inc., a San Francisco based diagnostic technology company. From January 2014 until June 2017, Mr. Carr served as non-executive Chairman, and from March 2012 to December 2013 as Chairman and Chief Executive Officer, of Regional Diagnostic Laboratories, Inc., a company founded to invest in various types of domestic and international medical laboratories. From October 2016 until May 2017, Mr. Carr was a board member of privately held Acuamark Diagnostics. Previously, Mr. Carr was a co-founder, Chief Executive Officer and director for OralDNA Labs, a privately held diagnostic company which was acquired by Quest Diagnostics. Mr. Carr was also a co-founder and the Chairman and Chief Executive Officer of American Esoteric Laboratories until it was acquired by publicly-held Sonic Healthcare Limited. Prior to that, Mr. Carr was President and a director of AmeriPath, Inc., a publicly-traded anatomic pathology company. Mr. Carr is a CPA (inactive) and has previous experience in Big Four public accounting firms as well as international consulting in Brazil, China and Spain.